Works matching IS 00302414 AND DT 2023 AND VI 101 AND IP 9

Results: 8

Front & Back Matter.

Published in:: Oncology, 2023, v. 101, n. 9, p. 1, doi. 10.1159/000533949
Publication type:: Article

Effectiveness of Palonosetron, 1-Day Dexamethasone, and Aprepitant in Patients Undergoing Carboplatin-Based Chemotherapy.

Published in:

Oncology, 2023, v. 101, n. 9, p. 584, doi. 10.1159/000531318

By:

Hayashi, Toshinobu;
Shimokawa, Mototsugu;
Matsuo, Koichi;
Uchiyama, Masanobu;
Kawada, Kei;
Nakano, Takafumi;
Egawa, Takashi

Publication type:

Article

Response Prediction Model of Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Retrospective Study.

Published in:

Oncology, 2023, v. 101, n. 9, p. 565, doi. 10.1159/000531317

By:

Ueno, Masaki;
Kosaka, Hisashi;
Iida, Hiroya;
Ida, Yoshiyuki;
Aoi, Kazunori;
Mori, Haruki;
Miyamoto, Atsushi;
Nishida, Yuko;
Hayami, Shinya;
Kawai, Manabu;
Kaibori, Masaki

Publication type:

Article

Overexpression of SOX2 Gene by Histone Modifications: SOX2 Enhances Human Prostate and Breast Cancer Progression by Prevention of Apoptosis and Enhancing Cell Proliferation.

Published in:

Oncology, 2023, v. 101, n. 9, p. 591, doi. 10.1159/000531195

By:

Kar, Swayamsiddha;
Niharika;
Roy, Ankan;
Patra, Samir Kumar

Publication type:

Article

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria.

Published in:

Oncology, 2023, v. 101, n. 9, p. 575, doi. 10.1159/000530987

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Fujimasa;
Kato, Kanako;
Fukunishi, Yoshiko;
Yanagihara, Emi;
Kato, Masaya;
Saneto, Hironobu;
Izumoto, Hirofumi;
Ueki, Hidetaro;
Yoshino, Takeaki;
Kitahata, Shogo;
Kawamura, Tomoe;
Kuroda, Taira;
Suga, Yoshifumi;
Miyata, Hideki;
Hirooka, Masashi;
Abe, Masanori;
Matsuura, Bunzo;
Ninomiya, Tomoyuki

Publication type:

Article

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

Published in:

Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Efficacy of Lipophilic Statins on Outcomes of Patients Treated with Immune Checkpoint Inhibitors.

Published in:

Oncology, 2023, v. 101, n. 9, p. 537, doi. 10.1159/000529644

By:

Chiang, Cho-Han;
Chen, Yuan-Jen;
See, Xin Ya;
Chang, Yu-Cheng;
Wang, Shih-Syuan;
Peng, Chun-Yu;
Horng, Chuan-Sheng;
Hsia, Yuan Ping;
Chiang, Cho-Hung;
Peng, Cheng-Ming;
Chiang, Cho-Hsien

Publication type:

Article

Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment Algorithm.

Published in:

Oncology, 2023, v. 101, n. 9, p. 553, doi. 10.1159/000527716

By:

Hingorani, Mohan;
Goody, Rebecca;
Bozas, Georgios;
Zahid, Khwaja;
Mitton, David James;
Jain, Prashant;
Wong, Vincent;
Roy, Rajarshi

Publication type:

Article